. This is now being replaced (a) by more systematic epidemiological surveys, and (b) by the introduction of independent routine carcinogenicity testing of all kinds of substances to which man might be exposed. We are still, in fact, at a transition stage in this change-over.
The new approach was prompted by the growing realization that the environment played a far greater role in human cancer development than had previously been supposed, with industrial exposure constituting a relatively small proportion of the overall carcinogenic risk (see WHO, 1964; Higginson & Muir, 1976; Doll, 1977) . The real purpose of the new approach, especially that of routine testing, was to anticipate knowledge of carcinogenic action, and thereby to facilitate the introduction of preventive measures 10-30 years earlier than would be possible if one waited each time until clinical evidence of an association became available.
But the change in approach raised 3 important questions: (1) how to acquire such information on a scale hardly possible by standard animal testing; (2) how to establish the accuracy of the results obtained by the new (alternative) testing methods; and (3) how to interpret the information thus acquired in terms of human risks.
Mutagenicity tests ) and other short-term methods of assay (see Goldenberg, 1974; Bridges, 1976; Purchase et al., 1978) are designed to overcome the first of these problems, namely, to cope with large-scale testing by relatively simple methods capable of yielding quick results. The accuracy is checked by comparing the results with available data from animal testing (McCann et al., 1975; Bartsch, 1976; Ashby & Styles, 1978) Berenblum, 1974) makes it abundantly clear that such an oversimplified concept of carcinogenesis can only lead one astray in trying to assess the risks for man, as a guide to cancer prevention.
In the past, the distinction between carcinogenic and noncarcinogenic compounds was based on experimental findings that the former did produce tumours when administered to animals, while the latter did not. This is now being superseded by determining whether the compound is or is not mutagenic.
The criteria in the case of animal testing may be described as direct evidence, those used in mutagenicity testing as indirect evidence. There (Brookes, 1975; Miller, 1978; Irving, 1979 Berenblum, 1974; Stenbiick et al., 1974; Van Duuren, 1976; Slaga et al., 1978; Sivak, 1979) . .-This "two-stage theory of carcinogenesis", including the concept that neoplastically transformed cells are capable of persisting in a "dormant" state, was once thought to relate niainly to skin (in which it was first identified and carefully analysed) and was for long considered to be of limited, academic interest. It is now known to apply to many other tissues in the body and is strongly suspected of operating in man as well.
One of the reasons for the long delay in accepting the initiation-promotion principle in human carcinogenesis was, surprisingly enough, reluctance to acknowledge that cancer cells in man could remain dormant, until "awakened" by some appropriate stimulus. I say "surprisingly", because functional dormancy is, after all, one of the basic principles of ontogenesis. All cells in the body are known to carry the full complement of genes, derived from the fertilized ovum, but most of the genes remain repressed throughout life, only a few being allowed to express themselves, in any particular organ, permitting tissue differentiation. If normal genes can remain functionally dormant, why not "tumour" genes as well?
How promoting action-i.e., the "awakening" process-operates, is still unclear. Even less is known about the way promoting action eventually becomes self-perpetuating. These are problems of considerable theoretical importance with obvious practical implications, and intensive efforts are being made in many laboratories to try to find the answers (Slaga et al., 1978) .
Meanwhile, attention may be drawn to the relevance of the initiation-promotion principle to human carcinogenesis, from 3 different viewpoints: 1. The Ames test (or indeed any form of mutagenicity testing system) can only identify the initiating phase of carcinogenesis, and cannot therefore recognize pure promoting agents, potentially operative in man. 2. Initiating action alone (i.e., without subsequent promoting action) is generally ineffective in inducing tumours. Identification of promoting agents may thus have more relevance to human carcinogenesis than identification of initiating agents. This is another way of saying that the admittedly important and revealing evidence of mutagenicity may not be the most crucial information in relation to carcinogenic risks for man. 3. The exclusion of "complete" carcinogens from man's environment may have only limited scope for cancer prevention, whereas exclusion of independent promoting action may prove to be as important, if not more so.
This presents us with the most challenging problem of all-how to devise practical methods of identifying promoting agents. From what we know at present, it is hard to visualize one single testing system for all potential promoting agents by animal testing, let alone by any short-term technique. A few experimental models for systemic promoting action in animals have been devised in recent years, but these would seem to be too complicated for routine purposes.
I might refer, in this connection, to our own current attempts at transplacental 2-stage carcinogenesis in animals, with a "broad-spectrum" initiator administered to the pregnant mother and the potential promoter to the offspring after birth (Armuth & Berenblum, 1979) .
This symposium is perhaps not the appropriate occasion to enlarge on the different methods of cancer prevention, except to refer briefly to the 4 hypothetical points of attack (Berenblum, 1974) : (i) by eliminating "complete" carcinogens from the environment (the conventional method of cancer prevention in man); (ii) by eliminating initiators from man's environment (based on results of mutagenicity tests); (iii) by eliminating the various promoting factors during the long latent period of carcinogenesis (for which no satisfactory testing systems exist at present); and (iv) by interfering with the carcinogenic process, as distinct from eliminating the incriminating factors (a possibility still at the experimental stage of enquiry (see Wattenberg, 1978) though the results are sufficiently encouraging to offer reasonable prospects of future application).
To conclude, we seem to have come a long way from when the conflict between chemical specificity and chemical diversity of carcinogenic agents dominated our thinking in trying to understand how carcinogens act. The common factor among the diverse agents can now be traced to similarities in reactivity of their metabolic products, rather than to physico-chemical or structural properties of the parent compounds. At a more practical level, epidemiological studies have brought to light a great variety of behavioural, social, dietetic, occupational, and other factors in man's mode of life, which influence his chances of developing cancer (some acting additively, and others apparently as promoting factors); while chemical analysis of air and water pollutants, food contaminants, etc., have added to our knowledge of potential carcinogens in the environment.
Naturally, the more information we can gather about specific carcinogens in our environment and the more we discover about the various kinds of tumour promotion operating in man, the better our chances will be in reducing the prevailing cancer incidence. But in the final analysis carcinogenesis is a biological problem, and only by taking cognizance of the biological process, with all its complications, can a rational procedure be formulated in trying to eradicate the disease. Practical applications often call for a pragmatic approach, but a proper understanding of the basic principles is necessary to avoid drawing false conclusions and to minimize the chances of following up false leads.
